Tammy J. Bungard

1.9k total citations
68 papers, 1.4k citations indexed

About

Tammy J. Bungard is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Tammy J. Bungard has authored 68 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cardiology and Cardiovascular Medicine, 30 papers in Internal Medicine and 11 papers in Geriatrics and Gerontology. Recurrent topics in Tammy J. Bungard's work include Atrial Fibrillation Management and Outcomes (41 papers), Venous Thromboembolism Diagnosis and Management (30 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Tammy J. Bungard is often cited by papers focused on Atrial Fibrillation Management and Outcomes (41 papers), Venous Thromboembolism Diagnosis and Management (30 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Tammy J. Bungard collaborates with scholars based in Canada, United States and Australia. Tammy J. Bungard's co-authors include Ross T. Tsuyuki, Finlay A. McAlister, William A. Ghali, Koon Teo, Pramodini Kale-Pradhan, Nesé Yuksel, Jeffrey Johnson, Bruce Ritchie, Margaret L. Ackman and Kari L. Olson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Geriatrics Society and The Annals of Thoracic Surgery.

In The Last Decade

Tammy J. Bungard

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tammy J. Bungard Canada 16 961 357 242 227 219 68 1.4k
Margie R. Goulding United States 11 825 0.9× 411 1.2× 225 0.9× 215 0.9× 127 0.6× 15 1.3k
David Battleman United States 17 607 0.6× 191 0.5× 117 0.5× 65 0.3× 210 1.0× 32 1.1k
Carmen Suárez Spain 22 1.0k 1.1× 709 2.0× 144 0.6× 79 0.3× 304 1.4× 87 1.8k
Kurt Bestehorn Germany 21 1.9k 2.0× 171 0.5× 237 1.0× 67 0.3× 257 1.2× 68 2.5k
Kami White United States 11 1.4k 1.4× 263 0.7× 132 0.5× 72 0.3× 73 0.3× 14 1.7k
Gang Fang United States 20 408 0.4× 113 0.3× 212 0.9× 106 0.5× 80 0.4× 38 961
Stéphane Steurbaut Belgium 19 475 0.5× 134 0.4× 155 0.6× 421 1.9× 109 0.5× 76 1.1k
Sue Hee Sung United States 21 1.1k 1.2× 217 0.6× 137 0.6× 33 0.1× 181 0.8× 65 1.6k
Gail Wygant United States 18 784 0.8× 476 1.3× 153 0.6× 52 0.2× 128 0.6× 41 1.2k
William Semchuk Canada 12 378 0.4× 113 0.3× 184 0.8× 317 1.4× 52 0.2× 55 821

Countries citing papers authored by Tammy J. Bungard

Since Specialization
Citations

This map shows the geographic impact of Tammy J. Bungard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tammy J. Bungard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tammy J. Bungard more than expected).

Fields of papers citing papers by Tammy J. Bungard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tammy J. Bungard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tammy J. Bungard. The network helps show where Tammy J. Bungard may publish in the future.

Co-authorship network of co-authors of Tammy J. Bungard

This figure shows the co-authorship network connecting the top 25 collaborators of Tammy J. Bungard. A scholar is included among the top collaborators of Tammy J. Bungard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tammy J. Bungard. Tammy J. Bungard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Gunther, Mary, et al.. (2020). Clinical Pharmacist Services on Admission to a Large Correctional Center. Journal of Correctional Health Care. 26(2). 105–112.
4.
Bungard, Tammy J., et al.. (2020). Carbamazepine Induction Impacting Apixaban Concentrations: A Case Report. CJC Open. 2(5). 423–425. 5 indexed citations
5.
Turgeon, Ricky D., William Semchuk, Peter Thomson, & Tammy J. Bungard. (2019). Exploring discrepancies between pharmacists’ perceived and actual roles towards optimising care in patients prescribed direct oral anticoagulants: a survey. Journal of Pharmacy Practice and Research. 49(4). 324–330. 1 indexed citations
6.
Bungard, Tammy J., et al.. (2018). Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals. BMJ Open. 8(10). e022065–e022065. 5 indexed citations
8.
Koshman, Sheri L., et al.. (2017). Venous Thromboembolism Prophylaxis on General Internal Medicine Units: Are Patients Well Served by Current Practice?. The Canadian Journal of Hospital Pharmacy. 70(3). 200–206. 4 indexed citations
9.
Simpson, Scot H., et al.. (2017). Provincial Comparison of Pharmacist Prescribing in Canada Using Alberta’s Model as the Reference Point. The Canadian Journal of Hospital Pharmacy. 70(5). 349–357. 13 indexed citations
10.
Bungard, Tammy J., et al.. (2017). A randomized trial of restarting warfarin at maintenance versus loading doses following an elective procedure. Journal of Thrombosis and Thrombolysis. 44(4). 507–515. 5 indexed citations
11.
Szkotak, Artur, et al.. (2017). Apixaban Concentration with and without Coadministration of Carbamazepine: A Case with No Apparent Interaction. The Canadian Journal of Hospital Pharmacy. 70(6). 463–467. 10 indexed citations
12.
McMurtry, M. Sean, et al.. (2015). The Disconnect Between Novel Oral Anticoagulant Eligibility and Provincial Drug Coverage: An Albertan Anticoagulation Clinic Audit. Canadian Journal of Cardiology. 31(8). 1047–1050. 3 indexed citations
13.
Nerenberg, Kara, et al.. (2014). A case series of LMWH use in pregnancy: Should trough anti-Xa levels guide dosing?. Thrombosis Research. 134(6). 1234–1240. 30 indexed citations
14.
Bungard, Tammy J. & Brian Sonnenberg. (2010). Valvular Heart Disease: A Primer for the Clinical Pharmacist. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(1). 76–91. 3 indexed citations
16.
Bungard, Tammy J., et al.. (2008). Anticoagulation Clinics in North America: Operational Insights. The Canadian Journal of Hospital Pharmacy. 61(4). 6 indexed citations
18.
McLean, Donna, et al.. (2006). Community Pharmacist Practices in Hypertension Management. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 139(3). S10–S10. 1 indexed citations
19.
Breault, René R., et al.. (2005). Warfarin Dosing after Initiation of Fenofibrate. The Canadian Journal of Hospital Pharmacy. 58(1). 2 indexed citations
20.
Olson, Kari L., Tammy J. Bungard, & Ross T. Tsuyuki. (2001). Cholesterol Risk Management: A Systematic Examination of the Gap from Evidence to Practice. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(7). 807–817. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026